SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received a De Novo approval by the U.S. Food and Drug ...
Please provide your email address to receive an email when new articles are posted on . AI module for the detection of hypertrophic cardiomyopathy gains de vovo FDA approval. The module is integrated ...
SAP today announced it has agreed to acquire AI-powered talent acquisition firm SmartRecruiters to bolster its SuccessFactors human capital management (HCM) suite. During a media briefing, Daniel Beck ...